Cas:499-44-5 Hinokitiol manufacturer & supplier

Chemical Name:Hinokitiol

CAS.NO:499-44-5

Synonyms:Isopropyltropolone;2-Hydroxy-6-(propan-2-yl)cyclohepta-2,4,6-trien-1-one;B-THUJAPLICIN;2,4,6-cycloheptatrien-1-one, 2-hydroxy-6-(1-methylethyl)-;2-Hydroxy-6-(propan-2-yl)cyclohepta-2,4,6-trien-1-on;beta-thujaplicin;4-ISOPROPYLTROPOLONE;MFCD00040180;2-Hydroxy-4-isopropylcyclohepta-2,4,6-trien-1-one;2,4,6-Cycloheptatrien-1-one, 2-hydroxy-4-(1-methylethyl)-;β-Thujaplicine;EINECS 207-880-7;Hinokitiol;β-Thujaplicin;Hinokitol;2-Hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one;2-hydroxy-4-(1-methylethyl)-2,4,6-cycloheptatrien-1-one

Molecular Formula:C₁₀H₁₂O₂

Molecular Weight:164.201

HS Code:2914400090

Physical and Chemical Properties:

Melting point:50-52 °C(lit.)

Boiling point:303.4±35.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.554

PSA:37.30000

Exact Mass:164.083725

LogP:1.89

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Isopropyltropolone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-hydroxy-4-(1-methylethyl)-2,4,6-cycloheptatrien-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hinokitiol Use and application,EINECS 207-880-7 technical grade,usp/ep/jp grade.

Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. Hinokitiol manufacturer He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. Hinokitiol supplier He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. Hinokitiol vendor Britons being brought from Wuhan to the UK are being placed in quarantine at Arrowe Park Hospital in the Wirral, northwest England, Raab said. Hinokitiol factory Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms.